Methyl 3-(2-anilino-1,3-oxazol-5-yl)benzoate;methyl 3-[2-(2,4-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(2,6-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(4-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 4-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate
C102H77F7N12O18 — CID 158814198
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 3-(2-anilino-1,3-oxazol-5-yl)benzoate;methyl 3-[2-(2,4-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(2,6-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(4-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 4-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate
Methyl 3-(2-anilino-1,3-oxazol-5-yl)benzoate;methyl 3-[2-(2,4-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(2,6-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(4-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 4-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate (PubChem CID 158814198) has the molecular formula C102H77F7N12O18 and a molecular weight of 1891.79 g/mol. Its IUPAC name is methyl 3-(2-anilino-1,3-oxazol-5-yl)benzoate;methyl 3-[2-(2,4-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(2,6-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(4-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 4-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate.
Molecular Properties
| Compound Name | Methyl 3-(2-anilino-1,3-oxazol-5-yl)benzoate;methyl 3-[2-(2,4-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(2,6-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(4-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 4-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate |
|---|---|
| PubChem CID | 158814198 |
| Molecular Formula | C102H77F7N12O18 |
| Molecular Weight | 1891.79 g/mol |
| Exact Mass | 1890.54 |
| IUPAC Name | methyl 3-(2-anilino-1,3-oxazol-5-yl)benzoate;methyl 3-[2-(2,4-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(2,6-difluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 3-[2-(4-fluoroanilino)-1,3-oxazol-5-yl]benzoate;methyl 4-[2-(3-fluoroanilino)-1,3-oxazol-5-yl]benzoate |
| SMILES | COC(=O)c1ccc(-c2cnc(Nc3cccc(F)c3)o2)cc1.COC(=O)c1cccc(-c2cnc(Nc3c(F)cccc3F)o2)c1.COC(=O)c1cccc(-c2cnc(Nc3ccc(F)cc3)o2)c1.COC(=O)c1cccc(-c2cnc(Nc3ccc(F)cc3F)o2)c1.COC(=O)c1cccc(-c2cnc(Nc3cccc(F)c3)o2)c1.COC(=O)c1cccc(-c2cnc(Nc3ccccc3)o2)c1 |
| InChI | InChI=1S/2C17H12F2N2O3.3C17H13FN2O3.C17H14N2O3/c1-23-16(22)11-5-2-4-10(8-11)14-9-20-17(24-14)21-15-12(18)6-3-7-13(15)19;1-23-16(22)11-4-2-3-10(7-11)15-9-20-17(24-15)21-14-6-5-12(18)8-13(14)19;1-22-16(21)12-5-2-4-11(8-12)15-10-19-17(23-15)20-14-7-3-6-13(18)9-14;1-22-16(21)12-7-5-11(6-8-12)15-10-19-17(23-15)20-14-4-2-3-13(18)9-14;1-22-16(21)12-4-2-3-11(9-12)15-10-19-17(23-15)20-14-7-5-13(18)6-8-14;1-21-16(20)13-7-5-6-12(10-13)15-11-18-17(22-15)19-14-8-3-2-4-9-14/h2*2-9H,1H3,(H,20,21);3*2-10H,1H3,(H,19,20);2-11H,1H3,(H,18,19) |
| InChIKey | IVBHOMZDKFREIH-UHFFFAOYSA-N |
| XLogP | 24.20 |
| TPSA | 386.16 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 30 |
| Rotatable Bonds | 24 |
| Heavy Atoms | 139 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1891.79 |
| LogP ≤ 5 | 24.20 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 30 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158814198 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.